Assessment of New Molecular Entities Approved for Cancer Treatment in 2020

Claire E P Smith; Vinay Prasad

doi:10.1001/jamanetworkopen.2021.12558

Assessment of New Molecular Entities Approved for Cancer Treatment in 2020

JAMA Netw Open. 2021 May 3;4(5):e2112558. doi: 10.1001/jamanetworkopen.2021.12558.

Authors

Claire E P Smith¹, Vinay Prasad^{2

3}

Affiliations

¹ Hematology and Medical Oncology, Boston University School of Medicine, Boston, Massachusetts.
² Department of Medicine, University of California, San Francisco.
³ Department of Epidemiology and Biostatistics, University of California, San Francisco.

Abstract

This cross-sectional study of all hematology/oncology drugs approved by the US Food and Drug Administration in 2020 assesses the functioning of the drug approval process following disruptions related to the COVID-19 pandemic.

MeSH terms

Antineoplastic Agents*
Cross-Sectional Studies
Drug Approval / statistics & numerical data*
Humans
Neoplasms* / drug therapy
Neoplasms* / mortality
United States
United States Food and Drug Administration

Substances

Antineoplastic Agents